Different patterns of human serum procollagen C-proteinase enhancer1 (PCPE1)

Clinica Chimica Acta

Volumn 403, Issue 1-2, 2009, Pages 76-80

  Mesilaty Gross, Shlomit ^a   Anikster, Yair ^a   Vilensky, Bela ^a   Wolf, Ido ^a   Phillip, Moshe ^b   Gat Yablonski, Galia ^b  

^a SHEBA MEDICAL CENTER   (Israel)

^b SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

Author keywords

Biochemical marker; Collagen type I; Glycopattern; Procollagen C proteinase enhancer1

Indexed keywords

BONE MORPHOGENETIC PROTEIN; OLIGOSACCHARIDE; PROCOLLAGEN C PROTEINASE; SIALIC ACID;

ADULT; ARTICLE; BONE METASTASIS; BREAST CANCER; CHILD; CLINICAL ARTICLE; COLLAGEN METABOLISM; CONTROLLED STUDY; HUMAN; IMMUNODETECTION; INFANT; ISOELECTRIC FOCUSING; PREMATURITY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BONE NEOPLASMS; BREAST NEOPLASMS; CHILD; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GLYCOPROTEINS; GLYCOSYLATION; HUMANS; INFANT; ISOELECTRIC FOCUSING; MIDDLE AGED; PREGNANCY; PREMATURE BIRTH; SENSITIVITY AND SPECIFICITY; TERM BIRTH;

EID: 67349283546     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2009.01.024     Document Type: Article

References (29)

1. Hojima Y., van der Rest M., and Prockop D.J. Type I procollagen carboxyl-terminal proteinase from chick embryo tendons. Purification and characterization. J Biol Chem 260 (1985) 15996-16003
2. Kadler K.E., Hojima Y., and Prockop D.J. Assembly of collagen fibrils de novo by cleavage of the type I pC-collagen with procollagen C-proteinase. Assay of critical concentration demonstrates that collagen self-assembly is a classical example of an entropy-driven process. J Biol Chem 262 (1987) 15696-15701
3. Kessler E., Takahara K., Biniaminov L., Brusel M., and Greenspan D.S. Bone morphogenetic protein-1: the type I procollagen C-proteinase. Science 271 (1996) 360-362
4. Ge G., and Greenspan D.S. Developmental roles of the BMP1/TLD metalloproteinases. Birth Defects Res C Embryo Today 78 (2006) 47-68
5. Moali C., Font B., Ruggiero F., et al. Substrate-specific modulation of a multisubstrate proteinase. C-terminal processing of fibrillar procollagens is the only BMP-1-dependent activity to be enhanced by PCPE-1. J Biol Chem 280 (2005) 24188-24194
6. Takahara K., Kessler E., Biniaminov L., et al. Type I procollagen COOH-terminal proteinase enhancer protein: identification, primary structure, and chromosomal localization of the cognate human gene (PCOLCE). J Biol Chem 269 (1994) 26280-26285
7. Liepinsh E., Banyai L., Pintacuda G., Trexler M., Patthy L., and Otting G. NMR structure of the netrin-like domain (NTR) of human type I procollagen C-proteinase enhancer defines structural consensus of NTR domains and assesses potential proteinase inhibitory activity and ligand binding. J Biol Chem 278 (2003) 25982-25989
8. Mott J.D., Thomas C.L., Rosenbach M.T., Takahara K., Greenspan D.S., and Banda M.J. Post-translational proteolytic processing of procollagen C-terminal proteinase enhancer releases a metalloproteinase inhibitor. J Biol Chem 275 (2000) 1384-1390
9. Xu W., and Mitchell A.P. Yeast PalA/AIP1/Alix homolog Rim20p associates with a PEST-like region and is required for its proteolytic cleavage. J Bacteriol 183 (2001) 6917-6923
10. Rechsteiner M., and Rogers S.W. PEST sequences and regulation by proteolysis. Trends Biochem Sci 21 (1996) 267-271
11. Steiglitz B.M., Keene D.R., and Greenspan D.S. PCOLCE2 encodes a functional procollagen C-proteinase enhancer (PCPE2) that is a collagen-binding protein differing in distribution of expression and post-translational modification from the previously described PCPE1. J Biol Chem 277 (2002) 49820-49830
12. Hopkins D.R., Keles S., and Greenspan D.S. The bone morphogenetic protein 1/Tolloid-like metalloproteinases. Matrix Biol 26 (2007) 508-523
13. Pieper R., Gatlin C.L., Makusky A.J., et al. The human serum proteome: display of nearly 3700 chromatographically separated protein spots on two-dimensional electrophoresis gels and identification of 325 distinct proteins. Proteomics 3 (2003) 1345-1364
14. Grgurevic L., Macek B., Durdevic D., and Vukicevic S. Detection of bone and cartilage-related proteins in plasma of patients with a bone fracture using liquid chromatography-mass spectrometry. Int Orthop 31 (2007) 743-751
15. Wada Y., Azadi P., Costello C.E., et al. Comparison of the methods for profiling glycoprotein glycans-HUPO Human Disease Glycomics/Proteome Initiative multi-institutional study. Glycobiology 17 (2007) 411-422
16. Dumon M.F., Nau A., Hervouet M., Paccalin J., and Clerc M. Isoelectric focusing (IEF) and immunofixation for determination of disialotransferrin. Clin Biochem 29 (1996) 549-553
17. Durand G., and Seta N. Protein glycosylation and diseases: blood and urinary oligosaccharides as markers for diagnosis and therapeutic monitoring. Clin Chem 46 (2000) 795-805
18. Adar R., Kessler E., and Goldberg B. Evidence for a protein that enhances the activity of type I procollagen C-proteinase. Coll Relat Res 6 (1986) 267-277
19. Varki A. Sialic acids in human health and disease. Trends Mol Med 14 (2008) 351-360
20. Gerstenfeld L.C., Chipman S.D., Kelly C.M., Hodgens K.J., Lee D.D., and Landis W.J. Collagen expression, ultrastructural assembly, and mineralization in cultures of chicken embryo osteoblasts. J Cell Biol 106 (1988) 979-989
21. Seibel M.J. Biochemical markers of bone turnover: part I: biochemistry and variability. Clin Biochem Rev 26 (2005) 97-122
22. Mundy G.R. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2 (2002) 584-593
23. Reinholz G.G., Getz B., Pederson L., et al. Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts. Cancer Res 60 (2000) 6001-6007
24. Im G.I., Qureshi S.A., Kenney J., Rubash H.E., and Shanbhag A.S. Osteoblast proliferation and maturation by bisphosphonates. Biomaterials 25 (2004) 4105-4115
25. Sharp C.A., Linder C., and Magnusson P. Analysis of human bone alkaline phosphatase isoforms: comparison of isoelectric focusing and ion-exchange high-performance liquid chromatography. Clin Chim Acta 379 (2007) 105-112
26. Romppanen J., Punnonen K., Anttila P., Jakobsson T., Blake J., and Niemela O. Serum sialic acid as a marker of alcohol consumption: effect of liver disease and heavy drinking. Alcohol Clin Exp Res 26 (2002) 1234-1238
27. Freeze H.H., and Aebi M. Altered glycan structures: the molecular basis of congenital disorders of glycosylation. Curr Opin Struct Biol 15 (2005) 490-498
28. Yang L., and Grey V. Pediatric reference intervals for bone markers. Clin Biochem 39 (2006) 561-568
29. Seibel M.J. Clinical application of biochemical markers of bone turnover. Arq Bras Endocrinol Metabol 50 (2006) 603-620